These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25130427)
1. Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting. Gu Q; Yang X; Lin L; Li S; Li Q; Zhong S; Peng J; Cui Z Hepatology; 2014 Dec; 60(6):1929-41. PubMed ID: 25130427 [TBL] [Abstract][Full Text] [Related]
3. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide as a protector from nonalcoholic fatty liver disease. Vinciguerra M Hepatology; 2015 Jun; 61(6):2115-6. PubMed ID: 25308328 [No Abstract] [Full Text] [Related]
5. MOR23 deficiency exacerbates hepatic steatosis in mice. Kang W; Yang S; Roh J; Choi D; Lee HW; Lee JH; Park T FASEB J; 2024 Oct; 38(20):e70107. PubMed ID: 39417398 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice. Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748 [TBL] [Abstract][Full Text] [Related]
7. Magnolol Alleviates Inflammatory Responses and Lipid Accumulation by AMP-Activated Protein Kinase-Dependent Peroxisome Proliferator-Activated Receptor α Activation. Tian Y; Feng H; Han L; Wu L; Lv H; Shen B; Li Z; Zhang Q; Liu G Front Immunol; 2018; 9():147. PubMed ID: 29467759 [TBL] [Abstract][Full Text] [Related]
8. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes. Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390 [TBL] [Abstract][Full Text] [Related]
9. Involvement of adenosine monophosphate-activated protein kinase in the influence of timed high-fat evening diet on the hepatic clock and lipogenic gene expression in mice. Huang Y; Zhu Z; Xie M; Xue J Nutr Res; 2015 Sep; 35(9):792-9. PubMed ID: 26239949 [TBL] [Abstract][Full Text] [Related]
10. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057 [TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice. Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638 [TBL] [Abstract][Full Text] [Related]
12. Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha. Li G; Brocker CN; Yan T; Xie C; Krausz KW; Xiang R; Gonzalez FJ Mol Metab; 2018 Jan; 7():80-89. PubMed ID: 29146411 [TBL] [Abstract][Full Text] [Related]
13. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells. Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255 [TBL] [Abstract][Full Text] [Related]
14. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells. Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863 [TBL] [Abstract][Full Text] [Related]
15. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice. López-Oliva ME; Garcimartin A; Muñoz-Martínez E Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234 [TBL] [Abstract][Full Text] [Related]
16. Reply: To PMID 25130427. Gu Q; Cui Z Hepatology; 2015 Oct; 62(4):1327. PubMed ID: 25711644 [No Abstract] [Full Text] [Related]
17. Reply: To PMID 25130427. Gu Q; Cui Z Hepatology; 2015 Jun; 61(6):2116. PubMed ID: 25308170 [No Abstract] [Full Text] [Related]
18. Putative role of cationic amino acid transporter-3 in murine liver metabolism. Closs EI Hepatology; 2015 Oct; 62(4):1326-7. PubMed ID: 25712160 [No Abstract] [Full Text] [Related]